GLP-1 for PCOS and the fertility timeline: what to know before you start

TLDR. GLP-1 medications are evidence-based for PCOS: they improve insulin sensitivity, restore menstrual regularity in many patients, and produce meaningful weight loss. They are also contraindicated in pregnancy and require washout before conception. The recommended timeline: stop semaglutide at least 2 months before trying to conceive (the half-life is roughly one week, plus a margin for clearance), or stop tirzepatide at least 4 weeks before. Many PCOS patients see fertility improve specifically because the underlying insulin resistance and weight burden ease while on the medication.

Polycystic ovary syndrome is one of the highest-evidence indications for off-label GLP-1 use. The published data shows real improvements in insulin sensitivity, menstrual cycle regularity, androgen levels and weight, beyond what calorie restriction alone produces. For PCOS patients who are not actively trying to conceive, GLP-1 is one of the most effective metabolic interventions available.

For PCOS patients planning to become pregnant in the next 12-24 months, the picture is more complicated. The medications are contraindicated in pregnancy. The timing of starting and stopping is the question this article exists to answer.

What GLP-1 does for PCOS specifically

Three documented effects relevant to PCOS:

• Improves insulin sensitivity. PCOS is fundamentally an insulin-resistance condition. GLP-1 improves how cells respond to insulin, lowering compensatory hyperinsulinemia.
• Restores menstrual regularity. Patients with anovulatory cycles often resume regular ovulation within 3-6 months of GLP-1 treatment, even at sub-maximal doses.
• Reduces androgen levels. Total and free testosterone typically drop 15-30% over 6 months. Hirsutism, acne and androgenic alopecia improve.

Weight loss itself drives some of these effects, but GLP-1 produces metabolic improvements that exceed what equivalent weight loss from diet alone produces.

The pregnancy contraindication

GLP-1 medications are FDA Pregnancy Category X (Wegovy) or have explicit "stop before pregnancy" warnings on every label. The reasons:

• Animal teratogenicity data shows adverse fetal effects at clinically relevant doses
• Insufficient human pregnancy data to characterise risk
• Slowed gastric emptying may interfere with nutrient absorption during early pregnancy

The label recommendation is to stop GLP-1 medications at least 2 months before attempting pregnancy. Some obesity-medicine specialists recommend 3 months to allow full washout of semaglutide (half-life roughly 7 days) and tirzepatide (half-life roughly 5 days).

The recommended timeline if you want to conceive

Standard guidance from obesity-medicine specialists:

1. If you want to conceive in 6 months or less: do not start GLP-1 now. The wash-out plus restart-failure window is too tight.
2. If you want to conceive in 6-18 months: GLP-1 is appropriate. Start now to capture insulin-sensitivity gains and weight loss. Plan to stop 2-3 months before attempting conception.
3. If you want to conceive in 18+ months: GLP-1 is clearly appropriate. The metabolic improvements before conception measurably improve fertility outcomes.
4. If you're not planning to conceive in the foreseeable future: standard PCOS GLP-1 dosing applies. Reassess if pregnancy intent changes.

The transition: from GLP-1 to active conception

Stop the medication 8-12 weeks before attempting pregnancy. During the wash-out, your appetite returns to baseline, ovulation usually continues at the rate established on medication (improved over pre-treatment) and the metabolic gains persist for several months after stopping.

What to expect during the transition:

• Appetite returns gradually over 4-6 weeks as the receptor effects wear off
• Some weight regain is expected and not harmful; obesity-medicine specialists target stabilization, not continued loss, during this window
• Continue obesity-friendly habits: high protein, resistance training, sleep regularity. These persist after the medication
• Track ovulation more closely than you did on medication, because cycle regularity may shift again

If you become pregnant while on GLP-1

Stop the medication immediately. Contact your obstetrician same-day. Document the date of last injection. Most reported pregnancies on GLP-1 have proceeded to normal-outcome births based on current limited data, but the medication is not approved for use in pregnancy and the precautionary stop is the standard guidance.

This is a clinical question for an OB or maternal-fetal medicine specialist, not for your telehealth provider. Use the GLP-1 program for the medication only; loop in your regular OB for everything else.

Programs that handle PCOS competently

Form Health's obesity-medicine specialists treat PCOS as the metabolic condition it is, not just as a weight problem. They handle PA on Wegovy or Zepbound for PCOS patients where most programs default to cash-pay compounded. Knownwell's full primary-care model is the closest in the chart to an in-person endocrine-aware clinic; strongest pick if you want one care team handling PCOS, GLP-1 and fertility planning together. Mochi is the cheapest predictable path if you're cash-pay and not planning conception in the next 18 months.

See our best-for-PCOS rankings for the full breakdown.

Frequently asked questions

Can I use GLP-1 for PCOS?

Yes, when prescribed appropriately. GLP-1 medications improve insulin sensitivity (a core PCOS mechanism), produce meaningful weight loss, and restore menstrual regularity in many patients. The medication does not have a PCOS-specific FDA indication, but the obesity indication captures most PCOS patients who would benefit.

How long should I be off GLP-1 before trying to conceive?

Two months for semaglutide (Wegovy, Ozempic), four weeks for tirzepatide (Zepbound, Mounjaro). The semaglutide half-life is roughly one week; five half-lives is the standard washout for full clearance. Some clinicians prefer a longer margin (3 months) to be conservative. Tirzepatide clears faster.

Will stopping GLP-1 affect my fertility?

Stopping the medication often unmasks the underlying PCOS again: appetite returns, weight regain begins, insulin sensitivity decreases. For patients who lost meaningful weight while on the medication, the residual benefit (lower weight, better hormonal balance) usually persists for several months and may be enough to support conception in that window.

What if I get pregnant while on GLP-1?

Stop the medication immediately and contact your prescriber and OB. There is no FDA-approved use in pregnancy. Animal data suggests risk, human data is limited. The medication does not cause termination of an established pregnancy in known cases; the recommendation is to stop and monitor closely. See our pregnancy emergency article for the protocol.

Will my insurance cover GLP-1 for PCOS?

Depends on the diagnosis on the prescription. PCOS itself is rarely a covered indication on its own. Most PCOS patients qualify under the obesity indication (BMI 30 or higher, or 27 to 29.9 with PCOS as a comorbidity) at plans that accept PCOS in the comorbidity list. Coverage varies by PBM and plan.